Gadolinium Contrast Extravasation — Medical Management

Pathophysiology

Severity Assessment (First Step)

Immediate Management

• Disconnect the injector; do NOT remove the IV cannula yet.

• Attempt to aspirate as much extravasated contrast as possible through the existing cannula before removal.

• Elevate the affected extremity above the level of the heart to reduce swelling and promote lymphatic drainage.

• Cold compress (ice pack) — preferred for gadolinium extravasation; reduces swelling, pain, and local vasodilation.
• Apply for 15–20 minutes, 3–4 times/day for 24–48 hours.

• NSAIDs (e.g., Ibuprofen 400 mg TID orally) for pain and local inflammation.
• Paracetamol/acetaminophen 500–1000 mg if NSAIDs are contraindicated.

• Mild topical steroid (e.g., hydrocortisone 1% cream) to reduce local inflammation and erythema.

• Oral cetirizine 10 mg or diphenhydramine 25–50 mg.

Monitoring

• Reassess every 1–2 hours initially for signs of deterioration.
• Monitor for compartment syndrome signs: the 6 P's — Pain (disproportionate), Pressure (tense swelling), Pallor, Paresthesias, Paralysis, Pulselessness.
• Monitor skin for blistering or necrosis (rare with GBCAs).

Escalation — When to Refer

Key Points

• Gadolinium extravasation is less toxic than iodinated CT contrast due to lower volumes and osmolality, so severe tissue necrosis is uncommon.
• Most mild-to-moderate cases resolve within 24–72 hours with conservative management.
• Document the event, volume extravasated (estimated), and clinical course.
• True allergic reactions to gadolinium are rare (0.004–0.7%) but must be differentiated from simple extravasation (Harrison's, p. 11958).

Reference: Harrison's Principles of Internal Medicine, 21st Edition, pp. 11951, 11958 | ACR Manual on Contrast Media, 2021 (acr.org)

Management of Thrombophlebitis

⚠️ Key Risk Context

1. Superficial Vein Thrombosis (SVT) / Superficial Thrombophlebitis

A. General Measures

B. Pharmacological Management

• Ibuprofen 400–600 mg TID or Diclofenac 75 mg BD
• Reduce local pain and inflammation
• Do not prevent thrombus extension on their own

Fondaparinux 2.5 mg for 45 days is supported by the CALISTO trial and is recommended by guidelines when the thrombus is ≥5 cm in length or close to the saphenofemoral junction (SFJ).

• Diclofenac gel applied over the affected vein TID — useful adjunct for local pain relief.

C. Surgical/Interventional (Selected Cases)

2. Deep Vein Thrombophlebitis (DVT)

A. Anticoagulation (Mainstay of Treatment)

• Provoked DVT: 3 months
• Unprovoked DVT: 3–6 months minimum, consider indefinite
• Recurrent DVT or thrombophilia: Indefinite anticoagulation

B. Compression & Mobilization

• Graduated elastic compression stockings (30–40 mmHg) — reduce post-thrombotic syndrome
• Early ambulation with adequate anticoagulation is safe and encouraged

C. Catheter-Directed Thrombolysis (CDT)

• Consider for massive proximal DVT (iliofemoral) with limb threat (phlegmasia cerulea dolens)
• Reduces post-thrombotic syndrome

3. Septic (Suppurative) Thrombophlebitis

Management:

1. Remove the IV catheter immediately
2. Blood cultures × 2 before starting antibiotics
3. IV Antibiotics:
   • Empirical: Vancomycin (covers MRSA) IV + Pip-Taz or Cefazolin
   • Guided by culture results
4. Anticoagulation: Controversial but considered in extensive septic thrombosis
5. Surgical drainage/excision if abscess formation or failure to respond to antibiotics within 48–72 hours
6. Duration: 4–6 weeks of IV antibiotics if bacteremia confirmed

Summary Algorithm

Thrombophlebitis
    ├── Superficial (SVT)
    │       ├── Symptomatic relief: NSAIDs + compression + elevation
    │       ├── Anticoagulation: Fondaparinux 2.5 mg SC × 45 days
    │       └── Surgery if near SFJ
    ├── Deep (DVT)
    │       ├── DOAC (Rivaroxaban/Apixaban) — preferred
    │       ├── LMWH bridge if DOAC not suitable
    │       └── Duration: 3 months (provoked) to indefinite (unprovoked/recurrent)
    └── Septic
            ├── Remove catheter
            ├── Blood cultures → IV Antibiotics (Vancomycin-based)
            └── Surgery if abscess

References: Management of Varicose Veins of the Lower Extremities, Part II (pp. 9, 54) | Harrison's Principles of Internal Medicine, 21st Ed. | CALISTO Trial (Fondaparinux in SVT) | ASH VTE Guidelines 2020